台股 » 個股 » 旭富 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

旭富

(4119)
可現股當沖
  • 股價
    85.7
  • 漲跌
    ▲0.9
  • 漲幅
    +1.06%
  • 成交量
    82
  • 產業
    上市 生技醫療類股▼0.22%
  • 353人加入追蹤

    立即追蹤

  • 本地時間:14:30

     
旭富 (4119)籌碼相關-元大-三重 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

元大-三重 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/01/22085.0000.0085.7002720.01%
2025/01/2000.00584.5084.80-5272-1.84%
2025/01/14183.7000.0084.0012700.37%
2025/01/134.183.51483.7583.900.12690.02%
2025/01/090.189.00389.4088.50-3251-1.17%
2025/01/070.290.4000.0089.800.22470.08%
2024/12/11094.4000.0094.0002290.01%
2024/12/0900.000.394.5093.40-0.3224-0.13%
2024/12/06097.0000.0097.0002200.02%
2024/11/20197.40197.9097.8001720.00%
2024/11/120.393.9000.0094.300.31230.24%
2024/11/1100.00293.6093.30-2112-1.78%
2024/10/16289.90189.8090.2011290.78%
2024/10/15190.5000.0090.5011300.77%
2024/10/04091.0000.0091.7001350.01%
2024/09/2700.00189.8089.80-1135-0.74%
2024/09/2500.00389.3089.70-3141-2.12%
2024/09/2000.00288.5088.80-2146-1.36%
2024/09/1900.00688.2588.30-6148-4.03%
2024/09/1600.00187.8087.80-1152-0.66%
2024/08/30189.1000.0088.4011710.58%
2024/08/16188.90189.3089.3001860.00%
2024/07/31190.8000.0091.2012040.49%
2024/07/1200.00291.8091.80-2200-1.00%
2024/07/1100.00191.8091.80-1203-0.49%
2024/07/08391.0000.0091.3032031.48%
2024/06/0500.00592.9092.90-5220-2.26%
2024/05/3100.00892.5892.00-8230-3.47%
2024/05/3000.00992.3092.50-9230-3.90%
2024/05/2000.00393.6793.40-3233-1.29%
2024/05/1700.00293.9093.90-2230-0.87%
2024/05/1500.00291.3091.50-2222-0.90%
2024/05/13091.8000.0091.8002320.01%
2024/05/10390.20390.9090.9002400.00%
2024/05/07088.1000.0088.1002420.01%
2024/05/0300.00088.5088.500242-0.01%
2024/05/02388.6000.0088.8032441.23%
2024/04/30188.9000.0089.0012450.41%
2024/04/29289.1000.0089.2022460.81%
2024/04/2300.00687.8087.80-6252-2.38%
2024/04/2200.001386.3586.50-13254-5.11%
2024/04/10089.50289.5089.50-2261-0.76%
2024/03/1200.00689.1089.00-6278-2.16%
2024/03/04791.07590.9090.9022740.73%
2024/02/27791.6400.0091.5072812.49%
2024/02/26392.1000.0092.1032831.06%
2024/02/1500.00889.7089.90-8293-2.73%
2024/02/05191.60191.1091.1002910.00%
2024/02/02090.5000.0090.8002900.00%
水星生醫*攜手旭富製藥 簽訂MTA開發抗癲癇藥物Anue鉅亨-2024/04/15
旭富新產能到位本季營運看增 觀音新廠產能再增5成Anue鉅亨-2023/10/03
星國阿茲海默三期順利解盲 旭富獨供原料藥營運吞補丸Anue鉅亨-2022/11/23
旭富 相關文章